RxDoctor Payments DataLook up a doctor →

Daniel Hsia

Pediatric Endocrinology · Atlanta, GANPI 1417140997

Payments from drug & device makers

$1,819,484in general payments, 2019–2025

Across 1,690 payments — averaging $1076.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$798K
  • Eli Lilly$434K
  • Novo Nordisk AS$332K
  • Vivus LLC$126K
  • Takeda Pharmaceuticals U.S.A., Inc.$79K
  • Janssen Research & Development, LLC$32K
  • plus $19K from 2 others
$1,358in research payments, 2019–2025

Across 1 payment — averaging $1358.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1K

What the payments were for

  • Consulting fees$4,95077%
  • Travel & lodging$1,05617%
  • Food & beverage$3886%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,819,484 in reported general payments places this provider in the 95th percentile of 30 pediatric endocrinology providers in Georgia.

See all pediatric endocrinology providers in Georgia

Other pediatric endocrinology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →